Table 2.

Weighted site-level HCV care continuum outcomes in the integrated care centers (ICC) vs. usual care (UC) clusters^*

	Usual Care		ICC intervention
	Baseline	Evaluation	Baseline	Evaluation
Aware of HCV Ab+ status, n (site % range)	145 (0.6 – 7.3)	252 (0.03 – 14.4)	264 (0.08 – 17.4)	642 (1.0 – 37.7)
Linked to care among HCV RNA+, n (site % range)	60 (0.05 – 5·7)	108 (0 – 6.0)	122 (0 – 10.6)	201 (0.4 – 13.6)
Initiated HCV treatment, n (site % range)	30(0 – 6.7)	52 (0 – 4.9)	42 (0 – 6.0)	119 (0.5 – 9.0)
Achieved SVR, n (site % range)	8 (0 – 1.9)	25 (0 – 2.8)	9 (0 – 1.8)	47 (0.1 – 3.2)

^*Weighted using RDS-II weights; hepatitis C virus (HCV), antibody (Ab), sustained virologic response (SVR)

Linkage, treatment initiation, and SVR outcomes among HCV RNA+